Drugs for Rare Diseases (DRD)

Increasing timely access to medicines for patients suffering from rare diseases.

One in 12 Canadians, two-thirds of them children, suffer from a rare disease. IMC is committed to advocating for policies that increase timely access to medicines and treatments for patients suffering from rare diseases.

Newsroom

Breaking down and analyzing current events in the healthcare industry for our members, policy influencers and the Canadian public.

About

Our  member companies, which range from fledgling start-ups to established organizations, are revolutionizing healthcare through the discovery and development of […]

resources

Discover. Learn.
Understand.

Informative content to keep you up to date on the most pressing issues facing our industry.